Designing trials for devices in hypertension - What have we learned?

27 August 2017 (17:42 - 18:00)

Organised by:

Video

Slides

Sign in for access options

About the speaker

Professor Felix Mahfoud

University Hospital Basel, Basel (Switzerland)

4 More presentations in this session

Presentation thumbnail

State of the Art: device-based therapy for hypertension

Professor M. Lobo (London, GB)

Presentation thumbnail

Efficacy and safety results of endovascular baroreflex amplification (EBA) for resistant hypertension (CALM-FIM studies): a safety and proof-of-principle cohort study.

Doctor W. Spiering (Utrecht, NL)

Abstract Slides Video

Presentation thumbnail

Sham or no-sham control in trials of renal denervation for treatment resistant hypertension: a systematic meta-analysis

Doctor F. Fadl El Mula (Riyadh, SA)

Abstract Slides Video

Presentation thumbnail

Validating renal nerve stimulation-induced blood pressure changes as a predictor of clinical response to renal sympathetic denervation

Doctor M. de Jong (Zwolle, NL)

Access the full session

Session thumbnail

Device-based therapy for hypertension - Where next?

The Event

ESC Congress 2017

27 August 2017 17:42 CET

You may be interested in

Congress Session

HFA clinical trial course in a nutshell

17 May 2025

Congress Presentation

Randomized controlled pilot study comparing different digital solutions for the management of hypertensive patients: the HSMonitor-IT study.

5 April 2025

Congress Session

Renal denervation in hypertension management: back in prime position?

26 August 2023

Congress Presentation

External applicability of blood pressure-lowering drug trials to real-world patients with manifest cardiovascular disease

28 August 2020

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources